ClinicalTrials.govpublic full text
Eculizumab (Soliris) in Covid-19 Infected Patients
coronavirus, covid19, soliris, eculizumab, covid-19, complement, immunomodulation, ards, adult respiratory distress syndrome, corona virus, expanded access
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 992006
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.